OncoMatch/Clinical Trials/NCT07660627
Determining Minimal Residual Disease Using ctDNA Deep Sequencing
Is NCT07660627 recruiting? Yes, currently enrolling (Sep 2026). This NA trial studies non-drug interventions for esophageal adenocarcinoma.
Check if I qualifyExtracted eligibility criteria
Cancer type
Esophageal Carcinoma
Gastric Cancer
Pancreatic Cancer
Disease stage
Required: Stage 0, I, II
stage 0-2; locally advanced, potentially operable disease; metastatic disease
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT07660627 currently recruiting?
Yes, this trial is currently recruiting patients.
What disease stage is eligible?
Stage 0 or I or II is required.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages